Accumulation of 14-3-3 proteins in glial cytoplasmic inclusions in multiple system atrophy

被引:48
作者
Kawamoto, Y
Akiguchi, I
Nakamura, S
Budka, H
机构
[1] Kyoto Univ, Fac Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan
[2] Univ Vienna, Inst Neurol, Vienna, Austria
关键词
D O I
10.1002/ana.10361
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Glial cytoplasmic inclusions are the pathological hallmark of multiple system atrophy. However, the molecular mechanisms underlying the formation of glial cytoplasmic inclusions remain unclear. a-Synuclein, a major component of glial cytoplasmic inclusions, has the ability to interact with 14-3-3 proteins, which mediate several types of signal transduction pathways. To elucidate the role of these 14-3-3 proteins in patients with multiple system atrophy, we performed immunohistochemical studies on 14-3-3 in brain tissue specimens from 7 control subjects and from 15 patients with multiple system atrophy. In both control and multiple system atrophy cases, 14-3-3 immunoreactivity was observed mainly in the neuronal somata and proximal processes, as well as the nerve fibers. Even in the severely affected regions of patients with multiple system atrophy, 14-3-3 immunoreactivity generally was spared in the surviving neurons, some of which were strongly immunolabeled. In addition, numerous glial cytoplasmic inclusions were intensely immunostained, and neuronal cytoplasmic inclusions and dystrophic neurites were also immunoreactive for 14-3-3. Our results suggest that an aberrant accumulation of 14-3-3 proteins may occur in brains affected by multiple system atrophy, and that 14-3-3 proteins may be associated with the pathogenesis of multiple system atrophy.
引用
收藏
页码:722 / 731
页数:10
相关论文
共 47 条
[1]   14-3-3 PROTEINS - A HIGHLY CONSERVED, WIDESPREAD FAMILY OF EUKARYOTIC PROTEINS [J].
AITKEN, A ;
COLLINGE, DB ;
VANHEUSDEN, BPH ;
ISOBE, T ;
ROSEBOOM, PH ;
ROSENFELD, G ;
SOLL, J .
TRENDS IN BIOCHEMICAL SCIENCES, 1992, 17 (12) :498-501
[2]   IMMUNOCYTOCHEMICAL AND ULTRASTRUCTURAL STUDIES OF NEURONAL AND OLIGODENDROGLIAL CYTOPLASMIC INCLUSIONS IN MULTIPLE SYSTEM ATROPHY .1. NEURONAL CYTOPLASMIC INCLUSIONS [J].
ARIMA, K ;
MURAYAMA, S ;
MUKOYAMA, M ;
INOSE, T .
ACTA NEUROPATHOLOGICA, 1992, 83 (05) :453-460
[3]   HUMAN 14-3-3 PROTEIN - RADIOIMMUNOASSAY, TISSUE DISTRIBUTION, AND CEREBROSPINAL-FLUID LEVELS IN PATIENTS WITH NEUROLOGICAL DISORDERS [J].
BOSTON, PF ;
JACKSON, P ;
THOMPSON, RJ .
JOURNAL OF NEUROCHEMISTRY, 1982, 38 (05) :1475-1482
[4]   Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
NATURE MEDICINE, 1998, 4 (11) :1318-1320
[5]  
Dickson DW, 1999, BRAIN PATHOL, V9, P657
[6]   Widespread alterations of α-synuclein in multiple system atrophy [J].
Dickson, DW ;
Liu, WK ;
Hardy, J ;
Farrer, M ;
Mehta, N ;
Uitti, R ;
Mark, M ;
Zimmerman, T ;
Golbe, L ;
Sage, J ;
Sima, A ;
D'Amato, C ;
Albin, R ;
Gilman, S ;
Yen, SH .
AMERICAN JOURNAL OF PATHOLOGY, 1999, 155 (04) :1241-1251
[7]   14-3-3 proteins: Structure, function, and regulation [J].
Fu, HA ;
Subramanian, RR ;
Masters, SC .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :617-647
[8]   α-Synuclein is phosphorylated in synucleinopathy lesions [J].
Fujiwara, H ;
Hasegawa, M ;
Dohmae, N ;
Kawashima, A ;
Masliah, E ;
Goldberg, MS ;
Shen, J ;
Takio, K ;
Iwatsubo, T .
NATURE CELL BIOLOGY, 2002, 4 (02) :160-164
[9]  
Gai WP, 1999, J NEUROCHEM, V73, P2093
[10]   Multiple-system atrophy:: a new α-synuclein disease? [J].
Gai, WP ;
Power, JHT ;
Blumbergs, PC ;
Blessing, WW .
LANCET, 1998, 352 (9127) :547-548